GENE ONLINE|News &
Opinion
Blog

Regulatory
Special RSV vaccinesFDA ApprovalEuropean Commission
Recent Highlights of the RSV Vaccine Battle, with More Regulatory Approvals in Sight
2023-06-08
Trials & Approvals FDA ApprovalGene Therapy
Krystal Biotech’s First Topical Gene Therapy Approved by FDA
2023-06-06
Trials & Approvals Astellas PharmaFezolinetant
FDA Approves Astellas’ Non-hormonal Menopause Treatment After Extended Review
2023-05-19
Trials & Approvals Gilead Sciences
Gilead’s HDV Drug Headed Towards European Approval Even With FDA Rejection
2023-05-08
Trials & Approvals GSKRSV vaccines
GSK Wins Approval For World’s First RSV Vaccine
2023-05-08
Trials & Approvals FDA
Ascendis’ Hormone Drug Hits Another FDA Roadblock on Path to Approval
2023-05-02
Trials & Approvals Pneumococcal VaccineFDA Approval
Pfizer Racks Up Infant Indication for Pneumococcal Vaccine
2023-05-01
Trials & Approvals Fecal Microbiota TransplantationFDA Approval
Nestle and Seres Land First-Ever Fecal Microbiota Product Approval From FDA
2023-04-27
Trials & Approvals BiogenAmyotrophic Lateral Sclerosis
FDA Grants Biogen’s Ultra-Rare ALS Med Accelerated Approval
2023-04-26
Regulatory India
Sun Pharma Temporarily Pauses Shipments from Mohali Following FDA’s Mandate for Corrective Actions
2023-04-24
Trials & Approvals RocheDLBCLPolivy
Roche Could Set New DLBCL Treatment Standard with First-Line Polivy Indication
2023-04-19
Trials & Approvals Allogeneic Cell TherapyFDA Approval
Gamida’s Allogeneic Cell Therapy Snags FDA Approval for Blood Cancers
2023-04-18
Trials & Approvals ModernaCancer Vaccine
Moderna’s Cancer Vaccine to Enter Phase 3 Trials This Year
2023-04-17
Trials & Approvals ModernamRNA Vaccine
Moderna’s mRNA Flu Vaccine Development Slow Going as Data Rolls In
2023-04-11
Trials & Approvals KeytrudaLenvima
Merck, Eisai’s Keytruda-Lenvima Combo Fails in Melanoma and Colorectal Cancer Trials
2023-04-10
1 2 3 4 5 6 … 53
LATEST
Pfizer’s Q1 2024 Revenue Declines, Offset by Strong Performance of Non-COVID-19 Products
2024-05-03
Novo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion
2024-05-03
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
Taiwan Breakthrough: Next-Generation Sequencing Now Covered in Health Insurance, Benefitting 20,000 Cancer Patients Annually
2024-05-02
CellTech Accelerator and Cyto-Facto Inc. Forge Strategic Partnership to Advance CGT Industry Growth
2024-04-29
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top